BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29531031)

  • 1. Deletion of dopamine D
    Tomasella E; Bechelli L; Ogando MB; Mininni C; Di Guilmi MN; De Fino F; Zanutto S; Elgoyhen AB; Marin-Burgin A; Gelman DM
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3476-3481. PubMed ID: 29531031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective dopamine D2 receptor deletion from Nkx6.2 expressing cells causes impaired cognitive, motivation and anxiety phenotypes in mice.
    Bechelli L; Tomasella E; Cardoso SL; Belmonte M; Gelman DM
    Sci Rep; 2023 Nov; 13(1):19473. PubMed ID: 37945756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J; Mengod G
    Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex.
    Graham DL; Durai HH; Garden JD; Cohen EL; Echevarria FD; Stanwood GD
    ACS Chem Neurosci; 2015 Feb; 6(2):297-305. PubMed ID: 25393953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer's Disease.
    Spoleti E; La Barbera L; Cauzzi E; De Paolis ML; Saba L; Marino R; Sciamanna G; Di Lazzaro V; Keller F; Nobili A; Krashia P; D'Amelio M
    Mol Psychiatry; 2024 May; 29(5):1265-1280. PubMed ID: 38228889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional dysregulation causes altered modulation of inhibition by haloperidol.
    Brady LJ; Bartley AF; Li Q; McMeekin LJ; Hablitz JJ; Cowell RM; Dobrunz LE
    Neuropharmacology; 2016 Dec; 111():304-313. PubMed ID: 27480797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.
    Chung DW; Fish KN; Lewis DA
    Am J Psychiatry; 2016 Nov; 173(11):1131-1139. PubMed ID: 27444795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered dendritic distribution of dopamine D2 receptors and reduction in mitochondrial number in parvalbumin-containing interneurons in the medial prefrontal cortex of cannabinoid-1 (CB1) receptor knockout mice.
    Fitzgerald ML; Chan J; Mackie K; Lupica CR; Pickel VM
    J Comp Neurol; 2012 Dec; 520(17):4013-31. PubMed ID: 22592925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia.
    Arime Y; Saitoh Y; Ishikawa M; Kamiyoshihara C; Uchida Y; Fujii K; Takao K; Akiyama K; Ohkawa N
    Neuropsychopharmacology; 2024 Mar; 49(4):720-730. PubMed ID: 38049583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia.
    Boley AM; Perez SM; Lodge DJ
    Schizophr Res; 2014 Aug; 157(1-3):238-43. PubMed ID: 24888524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia.
    Stansfield KH; Ruby KN; Soares BD; McGlothan JL; Liu X; Guilarte TR
    Transl Psychiatry; 2015 Mar; 5(3):e522. PubMed ID: 25756805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition.
    Gilani AI; Chohan MO; Inan M; Schobel SA; Chaudhury NH; Paskewitz S; Chuhma N; Glickstein S; Merker RJ; Xu Q; Small SA; Anderson SA; Ross ME; Moore H
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7450-5. PubMed ID: 24794528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons.
    Mao W; Watanabe T; Cho S; Frost JL; Truong T; Zhao X; Futai K
    Eur J Neurosci; 2015 Apr; 41(8):1025-35. PubMed ID: 25816842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area.
    Krabbe S; Duda J; Schiemann J; Poetschke C; Schneider G; Kandel ER; Liss B; Roeper J; Simpson EH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1498-506. PubMed ID: 25675529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam.
    Du Y; Grace AA
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27432008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids.
    Citver AS; Shields AM; Ciaccia LM; Schulingkamp RJ; Raffa RB
    J Clin Pharm Ther; 2002 Jun; 27(3):161-8. PubMed ID: 12081629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2-Like Receptors Modulate Intrinsic Properties and Synaptic Transmission of Parvalbumin Interneurons in the Mouse Primary Motor Cortex.
    Cousineau J; Lescouzères L; Taupignon A; Delgado-Zabalza L; Valjent E; Baufreton J; Le Bon-Jégo M
    eNeuro; 2020; 7(3):. PubMed ID: 32321772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.
    Carlsson A; Carlsson ML
    Dialogues Clin Neurosci; 2006; 8(1):137-42. PubMed ID: 16640125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis.
    Iyo M; Tadokoro S; Kanahara N; Hashimoto T; Niitsu T; Watanabe H; Hashimoto K
    J Clin Psychopharmacol; 2013 Jun; 33(3):398-404. PubMed ID: 23609386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.